Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2) (Cth)

Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2)1

Statutory Rules 2004 No. 672

I, PHILIP MICHAEL JEFFERY, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.

Dated 8 April 2004

P. M. JEFFERY

Governor-General

By His Excellency’s Command

TONY ABBOTT

Minister for Health and Ageing

1Name of Regulations

 These Regulations are the Health Insurance (Pathology Services Table) Amendment Regulations 2004 (No. 2).

2Commencement

 These Regulations commence on 1 May 2004.

3Amendment of Health Insurance (Pathology Services Table) Regulations 2003

Schedule 1 amends the Health Insurance (Pathology Services Table) Regulations2003.

Schedule 1Amendments

(regulation 3)

  

[1]Schedule 1, Part 2, subrule 14 (2)

omit

or P11

[2]Schedule 1, Part 2, paragraph 16 (2) (d)

omit

authorities).

insert

authorities); or

[3]Schedule 1, Part 2, after paragraph 16 (2) (d)

insert

• (e)

  both approved pathology authorities are operated by the Commonwealth or an authority of the Commonwealth; or

• (f)

  both approved pathology authorities are operated by the same State or internal Territory or an authority of the same State or internal Territory.

[4]Schedule 1, Part 3, item 69363

substitute

69363 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69369, 69370, 69372, 69373 or 69375 has been performed) — 1 or more tests 28.85

[5]Schedule 1, Part 3, item 69369, column 3

omit

28.65

insert

28.85

[6]Schedule 1, Part 3, item 69370, column 3

omit

33.80

insert

36.10

[7]Schedule 1, Part 3, items 69372 and 69375

substitute

69372	Detection of microbial antigens or nucleic acids (not elsewhere described in this table) — 1 or more tests	28.85
69373	Detection of a virus or microbial antigen or nucleic acid from a respiratory tract specimen — 1 test	28.85
69374	2 or more tests described in item 69373	36.10
69375	Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by detection of microbial antigen or nucleic acid, including a service described in item 69363, 69369, 69370, 69372 or 69373 (if performed) — 1 test	28.85
69376	2 or more tests described in item 69375	36.10

[8]Schedule 1, Part 3, item 69444, column 2, paragraph (a)

substitute

• (a)

  the patient is Hepatitis C seropositive;

[9]Schedule 1, Part 3, item 71139, column 2

omit

a total lymphocyte count

insert

a total lymphocyte count or total leucocyte count

[10]Schedule 1, Part 3, after item 71145

insert

71146 Enumeration of CD34+ cells, only for the purposes of autologous or directed allogeneic haemopoietic stem cell transplantation, including a total white cell count 105.85

[11]Schedule 1, Part 3, item 73921, column 2

omit

(Item is subject to subrules 14 (9) and 16 (3))

insert

(Item is subject to rules 14, 15 and 16)

[12]Schedule 1, Part 4

before

Lignocaine LIGN 66800

insert

Leucocyte count — CD34 surface marker only — blood LMCD34 71146

[13]Schedule 1, Part 5

omit

Skin, resection of malignant melanoma with full evaluation including measurement of Breslow thickness and Clark level 5

insert

Skin, resection of malignant melanoma or melanoma in situ 5

Notes

1. These Regulations amend Statutory Rules 2003 No. 256, as amended by 2003 Nos. 295, 300 and 360; 2004 No. 66.

2. Notified in the Commonwealth of Australia Gazette